THOMAS APPIO - 29 Feb 2024 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
Chief Executive Officer, Director
Signature
/s/ Brianna M. Cetrulo, attorney-in-fact
Issuer symbol
BHC
Transactions as of
29 Feb 2024
Net transactions value
-$1,156,952
Form type
4
Filing time
04 Mar 2024, 16:19:13 UTC
Previous filing
05 Sep 2023
Next filing
03 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Award $0 +519,328 +54% $0.000000 1,486,338 29 Feb 2024 Direct F1
transaction BHC Common Shares, No Par Value Tax liability $28,632 -2,895 -0.19% $9.89 1,483,443 01 Mar 2024 Direct F2
transaction BHC Common Shares, No Par Value Tax liability $23,865 -2,413 -0.16% $9.89 1,481,030 01 Mar 2024 Direct F2
transaction BHC Common Shares, No Par Value Tax liability $236,084 -23,871 -1.6% $9.89 1,457,159 01 Mar 2024 Direct F2
transaction BHC Common Shares, No Par Value Tax liability $868,372 -87,803 -6% $9.89 1,369,356 01 Mar 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of restricted share units ("RSUs") which will vest one-half on each of the first two anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer ("Common Shares").
F2 This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.